Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-11

131I-radioisotope modified in PEGylation metal organic frameworks for sensitization in refractory differentiated thyroid cancer treatment

Shuai Jiang, Miao Yu, Haoyang Wang [...]

Journal of Biomaterials Applications

Retricted access

Review article

First published 2018-1

Lenvatinib – A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer

Yvonne Hewett, Subash Ghimire, Bilal Farooqi [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2014-11

Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer

Francis Worden

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2018-09

Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications

Douglas Van Nostrand

Thyroid®

Retricted access

Research article

First published 2019-09

Clinical,Pathological,and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer

Leila Shobab, Cristiane Gomes-Lima, Alexander Zeymo [...]

Thyroid®

Retricted access

Research article

First published 2020-02

Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences

Chie Masaki, Kiminori Sugino, Naoko Saito [...]

Thyroid®

Retricted access

Research article

First published 2024-01

Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers

David Toro-Tobon, John C. Morris, Crystal Hilger [...]

Thyroid®

Retricted access

Review article

First published 2013-04

Clinical,Safety,and Economic Evidence in Radioactive Iodine–Refractory Differentiated Thyroid Cancer: A Systematic Literature Review

Roger T. Anderson, John E. Linnehan, Vanita Tongbram [...]

Thyroid®

Retricted access

Research article

First published 2017-08

Cost Effectiveness of Lenvatinib,Sorafenib and Placebo in Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer

Leslie Wilson, Wei Huang, Linda Chen [...]

Thyroid®

Retricted access

Research article

First published 2019-11

Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol

Amir Iravani, Benjamin Solomon, David A. Pattison [...]

Thyroid®

Search results